XLO icon

Xilio Therapeutics

29 hedge funds and large institutions have $48.3M invested in Xilio Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

67% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 9

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$7.06M
2 +$1.37M
3 +$221K
4
CC
Cannell Capital
Wyoming
+$36.7K
5
NL
NWAM LLC
Washington
+$29K

Top Sellers

1 -$6.07M
2 -$4.82M
3 -$878K
4
Norges Bank
Norges Bank
Norway
-$356K
5
Renaissance Technologies
Renaissance Technologies
New York
-$136K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$8.16M
2
$8.03M
3
$7.06M
4
$6.46M
5
$4.2M
6
$3.97M
7
$2.6M
8
$1.94M
9
$1.32M
10
$1.31M
11
$1.21M
12
$636K
13
$416K
14
$243K
15
$221K
16
$135K
17
$83K
18
$80K
19
$50K
20
$46K
21
$38K
22
$38K
23
$29K
24
$29K
25
$20K